Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
Clinical Trial Listings
What are Clinical Trials?
Become a Clinical Trial Volunteer
FDA Approved Drugs
Professional Resources
Research Center Profiles
Market Research
Benchmark Reports
FDA Approved Drugs
Training Guides
Books
eLearning
Events
Newsletters
White Papers
SOPs
Clinical Trial Listings
WCG Clinical
Sign In
Create Account
Sign Out
My Account
Home
» Despite Small Size, Rare Disease Trials Can Have a Big Impact on Medical Advancements
Looking to read the full article? Subscribe today!
Rare Diseases
Despite Small Size, Rare Disease Trials Can Have a Big Impact on Medical Advancements
September 2, 2024
Mike Ingram
Rare disease advocacy groups often use the phrase “rare is not rare” to drive home the point that, although individual diseases and conditions might affect only a small number of people, together they constitute a large patient population.
Upcoming Events
21
Oct
MAGI@home Clinical Research Conference 2024
Featured Products
Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs
Best Practices for Clinical Trial Site Management
Featured Stories
Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials
Ask the Experts: Applying Quality by Design to Protocols
Clinical Trials Need Greater Representation of Obese Patients, Experts Say
FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
The information you need to adapt your monitoring plan to changing times.
Learn More Here